Literature DB >> 3109547

Severe bradycardia due to interaction of timolol eye drops and verapamil.

S D Pringle, C J MacEwen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3109547      PMCID： PMC1245165          DOI： 10.1136/bmj.294.6565.155-a

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  4 in total

1.  Beta-blockers in the treatment of chronic simple glaucoma.

Authors:  R A Hitchings
Journal:  Br Med J (Clin Res Ed)       Date:  1982-07-10

2.  Beta blockers and verapamil: a cautionary tale.

Authors:  S J Hutchison; A R Lorimer; A Lakhdar; S G McAlpine
Journal:  Br Med J (Clin Res Ed)       Date:  1984-09-15

3.  Timolol and glaucoma.

Authors:  E M Van Buskirk; F T Fraunfelder
Journal:  Arch Ophthalmol       Date:  1981-04

4.  Clinical and hemodynamic evaluation of propranolol in combination with verapamil, nifedipine and diltiazem in exertional angina pectoris: a placebo-controlled, double-blind, randomized, crossover study.

Authors:  D L Johnston; R Lesoway; D P Humen; W J Kostuk
Journal:  Am J Cardiol       Date:  1985-03-01       Impact factor: 2.778
  4 in total
  10 in total

Review 1.  beta-blockers. Drug interactions of clinical significance.

Authors:  I Blaufarb; T M Pfeifer; W H Frishman
Journal:  Drug Saf       Date:  1995-12       Impact factor: 5.606

2.  Tachycardia precipitated by topical homatropine.

Authors:  D Reid; J D Fulton
Journal:  BMJ       Date:  1989-09-23

3.  Timolol metabolism and debrisoquine oxidation polymorphism: a population study.

Authors:  M S Lennard; R V Lewis; L A Brawn; G T Tucker; L E Ramsay; P R Jackson; H F Woods
Journal:  Br J Clin Pharmacol       Date:  1989-04       Impact factor: 4.335

Review 4.  Topical dorzolamide 2%/timolol 0.5%: a review of its use in the treatment of open-angle glaucoma.

Authors:  D Ormrod; K McClellan
Journal:  Drugs Aging       Date:  2000-12       Impact factor: 3.923

5.  Meta-analysis of randomised controlled trials comparing latanoprost with timolol in the treatment of patients with open angle glaucoma or ocular hypertension.

Authors:  W Y Zhang; A L Po; H S Dua; A Azuara-Blanco
Journal:  Br J Ophthalmol       Date:  2001-08       Impact factor: 4.638

6.  Ganfort, a blinding drug to the physician.

Authors:  Lennard lee; Chris Turnbull; Mohammed Majid Akhtar; James Fleet
Journal:  BMJ Case Rep       Date:  2012-09-07

Review 7.  Systemic reactions to ophthalmic drug preparations.

Authors:  F T Fraunfelder; S M Meyer
Journal:  Med Toxicol Adverse Drug Exp       Date:  1987 Jul-Aug

Review 8.  Current concepts of pharmacotherapy in hypertension--ophthalmically administered beta blockers and their cardiopulmonary effects.

Authors:  D A Sica
Journal:  J Clin Hypertens (Greenwich)       Date:  2001 May-Jun       Impact factor: 3.738

9.  Association between Ophthalmic Timolol and Hospitalisation for Bradycardia.

Authors:  Nicole L Pratt; Emmae N Ramsay; Lisa M Kalisch Ellett; Tuan A Nguyen; Elizabeth E Roughead
Journal:  J Ophthalmol       Date:  2015-03-22       Impact factor: 1.909

10.  Bradycardia Shock Caused by the Combined Use of Carteolol Eye Drops and Verapamil in an Elderly Patient with Atrial Fibrillation and Chronic Kidney Disease.

Authors:  Riku Arai; Daisuke Fukamachi; Masaki Monden; Naotaka Akutsu; Nobuhiro Murata; Yasuo Okumura
Journal:  Intern Med       Date:  2020-08-22       Impact factor: 1.271
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.